(ADDV-B) ADDvise - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0007464862

ADDV-B: Laboratory Equipment, Medical Devices, Pharmaceuticals, Infrastructure

ADDvise Group AB (publ) is a leading supplier of equipment and solutions to healthcare and research facilities across the globe, including Europe, North America, South America, Asia, and other international markets. The company operates through two primary business units: Lab and Healthcare. The Lab business unit specializes in providing advanced laboratory furnishings, ventilation systems, climate-controlled environments, and specialized equipment tailored for the pharmaceutical and life sciences industries. This unit serves clients in sectors such as biotechnology, medical research, and pharmaceutical manufacturing, offering customized solutions to meet specific laboratory needs.

The Healthcare business unit focuses on developing and distributing medical equipment, pharmaceuticals, and consumables across various clinical specialties, including urology, gynecology, emergency care, and surgical applications. This unit also manufactures and markets surgical tables, as well as a range of cables, connectors, and wires used in medical settings. Additionally, the company provides rental and sales solutions for medical and laboratory equipment, particularly for clinical studies, and designs and installs customized cleanrooms, climate-controlled environments, and advanced air conditioning systems.

ADDvise Group AB (publ) further expands its portfolio by distributing medical devices such as continuous glucose monitors, insulin pumps, and orthopedic solutions, including implants and surgical instruments. The company also develops software and instruments for assessing patient mobility, pain levels, and muscle strength. In the realm of diagnostics, it offers healthcare and industrial ultrasound devices for both medical applications and non-destructive testing (NDT) inspections. Other key offerings include a mail-order pharmacy service, over-the-counter generic medications for pain management and respiratory conditions, and colorimetric CO2 indicators used to monitor breathing in critical care settings.

Originally established in 1989 as ADDvise Lab Solutions AB (publ), the company rebranded to ADDvise Group AB (publ) to reflect its expanded scope and diversified product lines. Headquartered in Stockholm, Sweden, ADDvise Group AB (publ) has grown into a significant player in the global healthcare and life sciences equipment market, with a strong commitment to innovation and customer-centric solutions.

Ticker Symbol: ADDV-B Exchange: ST Type: Common Stock Country Origin: Sweden GICS Sub Industry: Life Sciences Tools & Services Based on the provided technical and fundamental data, here is a 3-month forecast for ADDvise Group B (ST:ADDV-B): The stock is currently trading at 2.35 SEK, below its SMA 50 (2.53) and significantly below its SMA 200 (5.12), indicating a bearish trend. The Average True Range (ATR) of 0.20 suggests low volatility. On the fundamental side, the company has a P/E ratio of 2.52 and a forward P/E of 2.04, indicating undervaluation relative to earnings. The price-to-book (P/B) ratio of 0.36 further supports this undervaluation, while the return on equity (RoE) of 10.78% reflects moderate profitability. Over the next three months, the stock is expected to remain under pressure due to the negative momentum indicated by the SMA crossover. However, the low P/S ratio of 0.20 and undervaluation metrics may attract value investors, potentially stabilizing the stock price. The low ATR suggests limited volatility, with price movements likely confined within a narrow range. Overall, the outlook is neutral to slightly bearish, with potential for limited upside if investor sentiment improves.

Additional Sources for ADDV-B Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ADDV-B Stock Overview

Market Cap in USD 44m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Life Sciences Tools & Services
IPO / Inception

ADDV-B Stock Ratings

Growth 5y 34.5%
Fundamental 46.8%
Dividend 1.0%
Rel. Strength Industry -78.3
Analysts -
Fair Price Momentum 1.38 SEK
Fair Price DCF 0.64 SEK

ADDV-B Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 1.0%

ADDV-B Growth Ratios

Growth Correlation 3m -83.1%
Growth Correlation 12m -96.2%
Growth Correlation 5y 57.3%
CAGR 5y 26.92%
CAGR/Max DD 5y 0.29
Sharpe Ratio 12m -2.09
Alpha -83.18
Beta -0.06
Volatility 137.68%
Current Volume 625.9k
Average Volume 20d 712k
What is the price of ADDV-B stocks?
As of March 14, 2025, the stock is trading at SEK 2.03 with a total of 625,948 shares traded.
Over the past week, the price has changed by -12.88%, over one month by +45.00%, over three months by -37.15% and over the past year by -78.38%.
Is ADDvise a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, ADDvise (ST:ADDV-B) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 46.83 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ADDV-B as of March 2025 is 1.38. This means that ADDV-B is currently overvalued and has a potential downside of -32.02%.
Is ADDV-B a buy, sell or hold?
ADDvise has no consensus analysts rating.
What are the forecast for ADDV-B stock price target?
According to ValueRays Forecast Model, ADDV-B ADDvise will be worth about 1.6 in March 2026. The stock is currently trading at 2.03. This means that the stock has a potential downside of -19.7%.
Issuer Forecast Upside
Wallstreet Target Price 8.7 328.6%
Analysts Target Price - -
ValueRay Target Price 1.6 -19.7%